About Guilin Sanjin Pharmaceutical Co., Ltd.
Guilin Sanjin Pharmaceutical Co., Ltd. is the core enterprise of the Sanjin Group and one of the earliest manufacturers of modern traditional Chinese medicine in China. Based in Guilin, Guangxi, the company is dedicated to the research, development and production of traditional Chinese medicines and natural medicines, and its English-language official website describes its evolution from a small Chinese medicine workshop into a nationally recognised pharmaceutical enterprise ranked among the leaders of the Chinese medicine industry.
The company reports more than 200 registered product varieties, including 47 independently developed exclusive products. Its best-known lines are the Guilin watermelon frost (watermelon cream) series and Sanjin tablets, with further recognised products such as watermelon frost lozenges and Naomai capsules, and a particularly strong position in throat, oral and urinary-system medicines.
Sanjin supports its manufacturing with a state-recognised enterprise technology centre, a postdoctoral research workstation and the Guangxi Traditional Chinese Medicine Industrialization Engineering Institute, and it has built the Sanjin Modern Traditional Chinese Medicine City in Guilin to consolidate production. Listed on the Shenzhen Stock Exchange since 2009, the company presents modernisation and internationalisation of traditional Chinese medicine as the centre of its long-term strategy.
The company reports more than 200 registered product varieties, including 47 independently developed exclusive products. Its best-known lines are the Guilin watermelon frost (watermelon cream) series and Sanjin tablets, with further recognised products such as watermelon frost lozenges and Naomai capsules, and a particularly strong position in throat, oral and urinary-system medicines.
Sanjin supports its manufacturing with a state-recognised enterprise technology centre, a postdoctoral research workstation and the Guangxi Traditional Chinese Medicine Industrialization Engineering Institute, and it has built the Sanjin Modern Traditional Chinese Medicine City in Guilin to consolidate production. Listed on the Shenzhen Stock Exchange since 2009, the company presents modernisation and internationalisation of traditional Chinese medicine as the centre of its long-term strategy.